Richard Teitelbaum A Jim Simons Market Mystery — Solved? A secretive investment fund backed by the legendary quant displays a penchant for biotech stocks. There’s a good reason for that. Richard Teitelbaum February 7, 2023 Bloomberg/Amanda Gordon